Psychosocial and pharmacological treatment for pediatric anxiety disorders

Paige H. Fisher, Jonathan L. Tobkes, Lauren Kotchern, Carrie Masia-Warner

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Anxiety disorders in children and adolescents are highly prevalent and associated with long-term impairment. This article reviews the main diagnostic features of the most common pediatric anxiety disorders, including specific phobia, separation anxiety disorder, generalized anxiety disorder and social anxiety disorder, and highlights the state-of-the-art treatments for these diagnoses. The most recent evidence for empirically supported treatments is described, namely cognitive-behavioral therapy and selective serotonin-reuptake inhibitors. The review concludes by providing practitioners with recommendations for treating pediatric anxiety and highlighting areas for further investigation.

Original languageEnglish
Pages (from-to)1707-1719
Number of pages13
JournalExpert Review of Neurotherapeutics
Volume6
Issue number11
DOIs
StatePublished - 1 Nov 2006

Fingerprint

Anxiety Disorders
Pharmacology
Pediatrics
Separation Anxiety
Serotonin Uptake Inhibitors
Cognitive Therapy
Therapeutics
Anxiety

Keywords

  • Anxiety disorders
  • Children
  • Cognitive-behavioral therapy
  • Fluoxetine
  • Fluvoxamine
  • Paroxetine
  • Sertraline

Cite this

Fisher, Paige H. ; Tobkes, Jonathan L. ; Kotchern, Lauren ; Masia-Warner, Carrie. / Psychosocial and pharmacological treatment for pediatric anxiety disorders. In: Expert Review of Neurotherapeutics. 2006 ; Vol. 6, No. 11. pp. 1707-1719.
@article{fe66a66a359e4e1ca2a5950c1521ae19,
title = "Psychosocial and pharmacological treatment for pediatric anxiety disorders",
abstract = "Anxiety disorders in children and adolescents are highly prevalent and associated with long-term impairment. This article reviews the main diagnostic features of the most common pediatric anxiety disorders, including specific phobia, separation anxiety disorder, generalized anxiety disorder and social anxiety disorder, and highlights the state-of-the-art treatments for these diagnoses. The most recent evidence for empirically supported treatments is described, namely cognitive-behavioral therapy and selective serotonin-reuptake inhibitors. The review concludes by providing practitioners with recommendations for treating pediatric anxiety and highlighting areas for further investigation.",
keywords = "Anxiety disorders, Children, Cognitive-behavioral therapy, Fluoxetine, Fluvoxamine, Paroxetine, Sertraline",
author = "Fisher, {Paige H.} and Tobkes, {Jonathan L.} and Lauren Kotchern and Carrie Masia-Warner",
year = "2006",
month = "11",
day = "1",
doi = "10.1586/14737175.6.11.1707",
language = "English",
volume = "6",
pages = "1707--1719",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
number = "11",

}

Psychosocial and pharmacological treatment for pediatric anxiety disorders. / Fisher, Paige H.; Tobkes, Jonathan L.; Kotchern, Lauren; Masia-Warner, Carrie.

In: Expert Review of Neurotherapeutics, Vol. 6, No. 11, 01.11.2006, p. 1707-1719.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Psychosocial and pharmacological treatment for pediatric anxiety disorders

AU - Fisher, Paige H.

AU - Tobkes, Jonathan L.

AU - Kotchern, Lauren

AU - Masia-Warner, Carrie

PY - 2006/11/1

Y1 - 2006/11/1

N2 - Anxiety disorders in children and adolescents are highly prevalent and associated with long-term impairment. This article reviews the main diagnostic features of the most common pediatric anxiety disorders, including specific phobia, separation anxiety disorder, generalized anxiety disorder and social anxiety disorder, and highlights the state-of-the-art treatments for these diagnoses. The most recent evidence for empirically supported treatments is described, namely cognitive-behavioral therapy and selective serotonin-reuptake inhibitors. The review concludes by providing practitioners with recommendations for treating pediatric anxiety and highlighting areas for further investigation.

AB - Anxiety disorders in children and adolescents are highly prevalent and associated with long-term impairment. This article reviews the main diagnostic features of the most common pediatric anxiety disorders, including specific phobia, separation anxiety disorder, generalized anxiety disorder and social anxiety disorder, and highlights the state-of-the-art treatments for these diagnoses. The most recent evidence for empirically supported treatments is described, namely cognitive-behavioral therapy and selective serotonin-reuptake inhibitors. The review concludes by providing practitioners with recommendations for treating pediatric anxiety and highlighting areas for further investigation.

KW - Anxiety disorders

KW - Children

KW - Cognitive-behavioral therapy

KW - Fluoxetine

KW - Fluvoxamine

KW - Paroxetine

KW - Sertraline

UR - http://www.scopus.com/inward/record.url?scp=33845429135&partnerID=8YFLogxK

U2 - 10.1586/14737175.6.11.1707

DO - 10.1586/14737175.6.11.1707

M3 - Review article

C2 - 17144784

AN - SCOPUS:33845429135

VL - 6

SP - 1707

EP - 1719

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

SN - 1473-7175

IS - 11

ER -